Fabiflu (Favipiravir)

• Delivery from India up to 30 days.
• Pack of 30 tablets.
• Manufactured by Glenmark, India.
• Pack of 34 tablets (200mg) and 17 tablets (400mg).

Buy Fabiflu Favipiravir at a bargain price in India

Fabiflu Favipiravir, a new antiviral drug from the Indian pharmaceutical company Glenmark, is used to treat severe flu.

The peculiarity of favipiravir as an antiviral agent is that the virus has no resistance to favipiravir. The drug retains its therapeutic effect from the first to the last patient in a flu pandemic or other fatal viral infection. Favipiravir is expected to be an important therapeutic agent for severe influenza and viral infections when standard treatment is ineffective.

Japanese pharmaceutical company Toyama Chemical created the active ingredient favipiravir in 2014 to treat influenza A virus, including poultry, pigs, and COVID-19 strains of the coronavirus. Favipiravir has been tested in the context of the 2020 pandemic, which prompted Indian manufacturer Aprazer to release Fabiflu, which has been approved for use in the fight against coronavirus in China, the United States, Italy and Russia.

Indications for use

When conservative treatment is ineffective, the main indication is the treatment of influenza patients.

The drug is active against single-stranded RNA viruses: influenza, yellow fever, West Nile fever, viral flaviviridae and Arenaviridae, Bunyaviridae, arboviruses of the Togaviridae family of group A, aphthous fever. As an experimental treatment, it has been shown to be highly effective in treating enterovirus and Rift Valley fever.

Currently, the drug Favipiravir is used as an experiment in the treatment of the coronavirus COVID-19. This drug affects strains resistant to treatment with amantadine, amantadine, oseltamivir, and zanamivir.

Contraindications

Favipiravir is not used to treat children, allergic reactions and pregnant women (including those suspected of being pregnant).

We recommend that you take extra care:

• Hyperuricemia and gout (if the patient is also sick);
• Patients with hepatic impairment.
• Side effects
• Adverse reactions during treatment with favipirum are rare.

However, there may be:

• Allergic reactions;
• Asthma, rhinitis, oropharyngeal pain;
• Jaundice, liver disease, hyperbilirubinemia;
• Stevens-Johnson syndrome, toxic epidermal necrolysis;
• Kidney damage, neutropenia, increased leukocytes, leukopenia;
• Convulsions, hallucinations, impaired consciousness;
• Nausea, abdominal pain, gastritis, hemorrhagic colitis and vomiting;
• Hypokalemia, hypertriglyceridemia and increased uric acid levels;
• Hematuria, pigmentation, skin bruises, dizziness, eye pain, ecstasystole, increased levels of creatine kinase in the blood.
• Special instructions
• Particular attention should be paid to the treatment of women and men of childbearing age. It is recommended to use an effective contraceptive barrier method within 7 days after taking the drug.

Breastfeeding women should stop breastfeeding.